Liminatus Pharma, Inc. - Class A Common Stock (LIMN)
13.35
+0.54 (4.22%)
NASDAQ · Last Trade: Jun 18th, 3:39 PM EDT
Via Benzinga · June 18, 2025
Via Benzinga · June 17, 2025
Via Benzinga · June 13, 2025
Via Benzinga · June 13, 2025
Via Benzinga · June 12, 2025
Via Benzinga · June 12, 2025
Via Benzinga · June 12, 2025
Via Benzinga · June 12, 2025
Via Benzinga · June 11, 2025
Via Benzinga · June 11, 2025
Via Benzinga · June 9, 2025
Via Benzinga · June 9, 2025
Via Benzinga · June 6, 2025

Via Benzinga · June 6, 2025

Via Benzinga · June 5, 2025

Via Benzinga · June 5, 2025

Via Benzinga · June 5, 2025

Via Benzinga · June 5, 2025

The company had previously faced a notice for delayed filings but has since rectified the issue.
Via Stocktwits · June 4, 2025